The field is expanding rapidly, and the complete peptide list continues to grow as new compounds are identified and characterized
The theoretical copper fraction in a 1:1 GHK-Cu complex is approximately 15.8% by weight, and each released lot is verified to fall within tolerance of that target
NAD+ therapy by injection requires a clinical setting
Published preclinical work often looks at cell migration, blood-vessel signalling, fibroblast activity, epithelial barrier models, and how local tissue environments respond under controlled conditions
Uses a longer needle, causes more discomfort, and is not the standard route for SS-31 in physician-supervised programs
Research quality note: Supplier formula listings can vary by salt form, counter-ion, acetate/TFA form or documentation style